Longer-term effects of intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy: Who benefits?

zu Verbundenen Objekten

Standort
Deutsche Nationalbibliothek Frankfurt am Main
Umfang
Online-Ressource
Sprache
Deutsch
Anmerkungen
Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Dissertation, 2024

Ereignis
Veröffentlichung
(wo)
Erlangen
(wer)
Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
(wann)
2024
Urheber
Beteiligte Personen und Organisationen
Lee, De-Hyung
Rothhammer, Veit

DOI
10.25593/open-fau-958
URN
urn:nbn:de:101:1-2409101426194.022462491846
Rechteinformation
Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
15.08.2025, 07:28 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

  • Terhoeven, Pauline
  • Lee, De-Hyung
  • Rothhammer, Veit
  • Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)

Entstanden

  • 2024

Ähnliche Objekte (12)

Intravenous immunoglobulin for inflammatory demyelinating polyneuropathy

Intravenous immunoglobulin for inflammatory demyelinating polyneuropathy

Measuring disease activity and predicting response to intravenous immunoglobulin in chronic inflammatory demyelinating polyneuropathy

Measuring disease activity and predicting response to intravenous immunoglobulin in chronic inflammatory demyelinating polyneuropathy

HBCU Enrollment and Longer-Term Outcomes

Arbeitspapier

HBCU Enrollment and Longer-Term Outcomes

Longer-term growth prospects for CESEE

Bericht

Longer-term growth prospects for CESEE

How I Treat Chronic Inflammatory Demyelinating Polyneuropathy Podcast

How I Treat Chronic Inflammatory Demyelinating Polyneuropathy Podcast

Inflammatory demyelinating polyneuropathy versus leptomeningeal disease following Ipilimumab

Inflammatory demyelinating polyneuropathy versus leptomeningeal disease following Ipilimumab

Reversible conduction failure in acute inflammatory demyelinating polyneuropathy

Reversible conduction failure in acute inflammatory demyelinating polyneuropathy

Clinical and economic comparison of an individualised immunoglobulin protocol vs. standard dosing for chronic inflammatory demyelinating polyneuropathy

Clinical and economic comparison of an individualised immunoglobulin protocol vs. standard dosing for chronic inflammatory demyelinating polyneuropathy

Safety and Tolerability of Intravenous Immunoglobulin in Chronic Inflammatory Demyelinating Polyneuropathy: Results of the ProCID Study

Safety and Tolerability of Intravenous Immunoglobulin in Chronic Inflammatory Demyelinating Polyneuropathy: Results of the ProCID Study

Sibling Health, Schooling and Longer-Term Developmental Outcomes

Arbeitspapier

Sibling Health, Schooling and Longer-Term Developmental Outcomes

IRIS manifesting as chronic inflammatory demyelinating polyneuropathy in HIV

IRIS manifesting as chronic inflammatory demyelinating polyneuropathy in HIV

Clinical and neurophysiological correlation in axonal and demyelinating polyneuropathy

Clinical and neurophysiological correlation in axonal and demyelinating polyneuropathy

Verbundene Objekte